Lab-Grown heart cells tested in humans for first time
NCT ID NCT05647213
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests whether heart cells grown from a patient's own stem cells are safe to inject into people with severe congenital heart disease. About 50 participants will receive the cells or be in a control group. The main goal is to check for serious side effects within three months and see if the process is practical. All participants will be followed for life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL HEART DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55901, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart surgery in childhood: a hidden impact on speech and memory?
- A website designed to steer teens with heart defects away from vaping
- AI stethoscope aims to spot hidden heart and lung problems in children
- Can community hospitals in zambia master severe disease care?
- App-Based exercise program aims to strengthen hearts in congenital disease
- Which nerve block eases Children's heart surgery pain better?